SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,118,618 | +75.6% | 9,228 | +65.9% | 0.09% | +45.8% |
| Q2 2023 | $636,960 | -43.2% | 5,562 | -31.7% | 0.06% | -78.1% |
| Q1 2023 | $1,121,936 | -31.3% | 8,140 | -35.4% | 0.27% | -33.1% |
| Q4 2022 | $1,633,485 | +1601.5% | 12,606 | +1349.0% | 0.40% | +2412.5% |
| Q3 2022 | $96,000 | +1820.0% | 870 | +1281.0% | 0.02% | +1500.0% |
| Q2 2022 | $5,000 | -68.8% | 63 | -63.8% | 0.00% | -83.3% |
| Q4 2021 | $16,000 | -15.8% | 174 | -17.1% | 0.01% | -14.3% |
| Q3 2021 | $19,000 | – | 210 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |